IFNG and lymphoma: CD3+T cells in lymphoma and MM autografts had a lower expression of the proliferation marker Ki67 and cytokine IFN-γ compared to CD3+T cells in allografts, supporting the idea that CD3+T cells in the autograft were less able to proliferate or secrete cytokines (Figure 2B).